在接受治疗性低温治疗的新生儿中Gentamicin的药理动力学对于低毒性缺血性脑病变的治疗性低温
Mamta Naik1, Emily Warden2, Rick Pittman3
1Department of Pharmacy Services, Children's Memorial Hermann Hospital-Texas Medical Center, 6411 Fannin Street, Houston, TX, 77030, USA. Mamta.Naik@memorialhermann.org.
Paediatric drugs
|October 24, 2024
概括
患有缺氧性缺血性脑病变 (HIE) 的新生儿经历治疗性低温 (TH) 可能会改变 gentamicin 的药理动力学. 这需要对这种脆弱人群进行仔细的监测和对传统剂量方案的潜在调整.
科学领域:
- 新生儿药理学 新生儿药理学
- 临床药理动力学 临床药理动力学
- 儿科重症监护 儿科重症监护
背景情况:
- 低毒性缺血性脑病变 (HIE) 是新生儿的一种严重疾病.
- 治疗性低温 (TH) 是HIE的标准治疗方法.
- 甘他素通常用于新生儿,但其药理动力学特征可能是可变的.
研究的目的:
- 审查新生儿中 gentamicin 的药物动力学概况,其中 HIE 接受 TH.
- 评估 gentamicin 最低水平及其在这个特定患者群体中的影响.
主要方法:
- 对接受TH治疗的HIE新生儿进行了回顾性研究.
- 数据收集包括人口统计,诊断,实验室结果,以及 gentamicin 的管理/监测.
- 使用SciPy.进行的分析.
主要成果:
- 61%的新生儿有 gentamicin 最低水平 (>2 mg/L) 的升高.
- 升高的水平与剂量间隔调整的显著差异有关 (P < 0.001).
- 14%的新生儿有高水平的失败了听力屏幕,虽然不是统计学上显著的 (P = 0.389).
结论:
- 接受TH治疗的HIE新生儿可能会表现出改变的 gentamicin 药理动力学.
- 频繁的监测和剂量调整至关重要.
- 目前的珍塔米辛剂量方案可能需要对这一群体进行修改,因此需要进一步研究替代策略.
相关概念视频
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
386
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
386
01:20Estimation of k and VD of Aminoglycosides
336
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
336
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
975
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
975
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
558
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
558
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
414
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
414
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
413
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
413